Cargando…
An update of clinical management of acute intermittent porphyria
Acute intermittent porphyria (AIP) is due to a deficiency of the third enzyme, the hydroxymethylbilane synthase, in heme biosynthesis. It manifests with occasional neuropsychiatric crises associated with overproduction of porphyrin precursors, aminolevulinic acid and porphobilinogen. The clinical cr...
Autores principales: | Pischik, Elena, Kauppinen, Raili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562648/ https://www.ncbi.nlm.nih.gov/pubmed/26366103 http://dx.doi.org/10.2147/TACG.S48605 |
Ejemplares similares
-
Pathogenesis of acute encephalopathy in acute hepatic porphyria
por: Pischik, Elena, et al.
Publicado: (2023) -
Pain in acute hepatic porphyrias: Updates on pathophysiology and management
por: Kazamel, Mohamed, et al.
Publicado: (2022) -
Long-term follow-up of acute porphyria in female patients: Update of clinical outcome and life expectancy
por: Baumann, Katrin, et al.
Publicado: (2022) -
Acute Intermittent Porphyria in Argentina: An Update
por: Cerbino, Gabriela Nora, et al.
Publicado: (2015) -
Acute intermittent porphyria
por: Syal, Kartik, et al.
Publicado: (2015)